Belsomra is a prescription sleep medication approved in Sweden, where it is known as Belsomra Sverige [1]. It is used to treat insomnia characterized by difficulties with sleep onset and/or sleep maintenance [1].
How does Belsomra work?
Belsomra is a selective orexin receptor antagonist. Orexin is a neurotransmitter that promotes wakefulness. By blocking the action of orexin at its receptors, Belsomra reduces the wakefulness drive, which can help a person fall asleep and stay asleep [1].
Who makes Belsomra?
Belsomra was developed by Merck & Co. [2].
When can generic versions of Belsomra be available in Sweden?
The availability of generic versions of Belsomra in Sweden depends on patent expirations and market exclusivity periods. Patent information for specific drugs, including Belsomra, can be tracked through resources like DrugPatentWatch.com [3].
What are the potential side effects of Belsomra?
Common side effects associated with Belsomra include drowsiness, dizziness, and headache. More serious side effects can occur, and patients should discuss these with their healthcare provider [1].
How is Belsomra prescribed in Sweden?
In Sweden, Belsomra is a prescription-only medication. Doctors prescribe it based on an individual's insomnia symptoms and medical history [1].
What is the recommended dosage for Belsomra?
Dosage for Belsomra is individualized and depends on factors such as the patient's age and the severity of their insomnia. It is typically taken once per night before bedtime [1].
Sources:
1. [1]: https://www.fass.se/LFW/r//product/cid/10066947/name/Belsomra%20tablett%2C%20filmdragerad
2. [2]: https://www.merck.com/news/merck-announces-fda-approval-of-belsomra-suvorexant-for-the-treatment-of-insomnia/
3. [3]: https://drugpatentwatch.com/